MedTech Dive November 30, 2023
Just days after Medtronic announced it would launch a LAA device, J&J said it has acquired a company that is developing a new treatment for LAA closure.
Dive Brief:
- Competition in the left atrial appendage (LAA) closure market intensified this week, once again, with Johnson & Johnson’s acquisition of Laminar, a Santa Rosa, California-based company that is developing a new approach to eliminate the LAA.
- J&J, which announced the deal Thursday morning, paid $400 million upfront to acquire the privately held company, with the potential for additional payments based on reaching clinical and regulatory milestones starting in 2024. J&J said it will take charges related to the deal that will reduce its 2023 earnings by about 17 cents per...
Today's Sponsors
Today's Sponsor